Earnings Preview: MCK, GM, META, UPS, PFE

It’s a busy week for earnings, with around 200 companies reporting. Some of these include Exxon Mobil Corp. (NYSE: XOM), AmerisourceBergen Corp. (NYSE: ABC), Cardinal Health, Inc. (NYSE: CAH), Phillips 66 (NYSE: PSX), Marathon Petroleum Corp. (NYSE: MPC), Humana Inc. (NYSE: HUM), T-Mobile US, Inc. (NASDAQ: TMUS), Sysco Corp. (NYSE: SYY), GE Healthcare Technologies, Inc. (NASDAQ: GEHC), MetLife, Inc. (NYSE: MET), and Caterpillar, Inc. (NYSE: CAT).

Here are some of the key earnings updates to look forward to this week:

McKesson (NYSE: MCK)

McKesson (NYSE: MCK) will release its Q3 fiscal 2023 financial results after the market close on Wednesday, February 1, 2023. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results. The live webcast will be available on McKesson’s Investor Relations website, along with the company’s earnings release, financial tables and slide presentation.

FactSet analyst estimates predict an EPS consensus of $6.36 and a sales consensus of $71bn.

The company recently declared a regular dividend of 54 cents per share of common stock. The dividend will be payable on April 3, 2023, to stockholders of record on March 1, 2023.

Over the past year, MCK stock has traded between $248.63 and $401.78. Today it trades at around $379. So far this year, the McKesson stock price is up 1.3%, while the S&P 500 has risen 6.4% over the same period.

17 FactSet analysts have a consensus Overweight rating on MCK stock with a target share price of $428.89.

MCK stock has a price-to-earnings ratio (P/E) of 27.2 and a dividend yield of 0.6%.

What Does McKesson Do?

McKesson Corporation is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Its team's partner with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products and services to help make quality care more accessible and affordable.

General Motors (NYSE: GM)

General Motors (NYSE: GM) is expected to report its Q4 and full-year 2022 earnings on Tuesday, Jan 31, 2023.

FactSet analyst estimates provide a full-year EPS consensus of $7.20 and a sales consensus of $154.3bn.

Over the past year, GM stock has traded between $30.33 and $55.55. Today it trades at around $37.95. Year-to-date, the General Motors stock price is up 12%.

22 FactSet analysts have a consensus Overweight rating on GM stock with a target share price of $46.76.

GM stock has a forward P/E of 6.4 (currently 6.2), and its P/BV is 0.8. GM stock comes with a 1% dividend yield.

What Does General Motors Do?

General Motors is a global company focused on advancing an all-electric future that is inclusive and accessible to all. At the heart of this strategy is the Ultium battery platform, which will power everything from mass-market to high-performance vehicles.

General Motors, its subsidiaries and its joint venture entities sell vehicles under the Chevrolet, Buick, GMC, Cadillac, Baojun and Wuling brands.

Meta (NASDAQ: META)

Meta (NASDAQ: META) will announce its Q4 2022 and full-year financial results after the market close on Wednesday, February 1, 2023.

FactSet analyst estimates provide an EPS consensus of $9.08 and a sales consensus of $115.9bn.

Over the past year, META stock has traded between $88.09 and $328. Today it trades at around $151.74. Year-to-date, the Meta stock price is up 21%.

60 FactSet analysts have a consensus Overweight rating on META stock with a target share price of $147.16.

META stock has a P/E of 14. Its P/BV is 3.2. It does not offer a dividend.

What Does Meta Do?

Meta builds technologies that help people connect, find communities, and grow businesses. When Facebook launched in 2004, it changed the way people connect. Apps like Messenger, Instagram, and WhatsApp further empowered billions around the world. Now, Meta is moving beyond 2D screens toward immersive experiences like augmented and virtual reality to help build the next evolution in social technology, the metaverse.

United Parcel Service (NYSE: UPS)

United Parcel Service (NYSE: UPS) will announce its 2022 fourth-quarter results on January 31, 2023, at approximately 6:00 a.m. Eastern Time.

FactSet analyst estimates provide an EPS consensus of $12.90 and a sales consensus of $101.35bn.

Over the past year, UPS stock has traded between $154.87 and $233.72. Today it trades at around $182. Year-to-date, the UPS stock price is up 3.8%.

UPS stock has a P/E of 14. Its P/BV is 9.2. UPS stock comes with a dividend yield of 3.4%.

29 FactSet analysts have a consensus Overweight rating on UPS stock with a target share price of $191.64.

What Does UPS Do?

United Parcel Service (UPS) is one of the world’s largest companies, with 2021 revenue of $97.3bn, and provides a broad range of integrated logistics solutions for customers in more than 220 countries and territories.

Pfizer (NYSE: PFE)

Pfizer (NYSE: PFE) will publish its fiscal year 2022 Q4 and full-year financial results on Tuesday, January 31, 2023. A live webcast of the earnings conference with investment analysts will commence at 10 a.m. EST.

FactSet analyst estimates provide an EPS consensus of $6.50 and a sales consensus of $100.49bn. EPS guidance comes between $6.40 and $6.50, with sales guidance of $99.5bn to $102bn.

Over the past year, PFE stock has traded between $41.44 and $56.32. Today it trades at around $43.79. Year-to-date, the Pfizer stock price is down -14.5%.

PFE stock has a P/E of 8.5. Its P/BV is 2.7. Pfizer stock comes with a dividend yield of 3.7%.

Pfizer recently announced that its board of directors declared an increase in the quarterly cash dividend on the company’s common stock to $0.41 for its Q1 2023 dividend, payable March 3, 2023, to holders of the Common Stock of record at the close of business on January 27, 2023. The first-quarter 2023 cash dividend will be the 337th consecutive quarterly dividend paid by Pfizer.

Dr. Albert Bourla, Pfizer Chairman and CEO, said:

Our ability to increase our dividend is a testament to our solid financial performance during 2022. This increase reinforces Pfizer’s commitment of returning value to our shareholders.

22 FactSet analysts have a consensus Overweight rating on PFE stock with a target share price of $54.24.

What Does Pfizer Do?

Pfizer is a biopharmaceutical company that applies science and global resources to bring therapies to people that extend and significantly improve their lives. The company has existed for over 170 years. It collaborates with healthcare providers, governments, and local communities to support and expand access to reliable, affordable healthcare around the world.